Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Asset Utilization Ratio (2021 - 2025)

Xeris Biopharma Holdings' Asset Utilization Ratio history spans 5 years, with the latest figure at 0.77 for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 22.83% year-over-year to 0.77, compared with a TTM value of 0.77 through Dec 2025, up 22.83%, and an annual FY2025 reading of 0.83, up 31.32% over the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.77 at Xeris Biopharma Holdings, up from 0.76 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.77 in Q4 2025, with the low at 0.2 in Q1 2022.
  • Average Asset Utilization Ratio over 5 years is 0.49, with a median of 0.5 recorded in 2023.
  • Year-over-year, Asset Utilization Ratio skyrocketed 84.37% in 2023 and then rose 22.83% in 2025.
  • Tracing XERS's Asset Utilization Ratio over 5 years: stood at 0.23 in 2021, then surged by 49.56% to 0.34 in 2022, then skyrocketed by 48.03% to 0.5 in 2023, then rose by 25.08% to 0.63 in 2024, then rose by 22.83% to 0.77 in 2025.
  • Per Business Quant, the three most recent readings for XERS's Asset Utilization Ratio are 0.77 (Q4 2025), 0.76 (Q3 2025), and 0.76 (Q2 2025).